Detalhe da pesquisa
1.
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle.
Immunity
; 56(10): 2254-2269, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699391
2.
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
Immunity
; 55(3): 527-541.e5, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35231421
3.
Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer.
Semin Immunol
; 48: 101406, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248905
4.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
5.
How molecularly similar are primary and metastatic tissues in renal cell carcinoma? - Authors' reply.
Lancet Oncol
; 23(7): e317, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772459
6.
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma.
J Immunother Cancer
; 11(11)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935564
7.
Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment.
Cancer Immunol Res
; 11(4): 530-545, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883368
8.
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.
Nat Rev Clin Oncol
; 19(7): 441-457, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365796
9.
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640928
10.
An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment.
Front Immunol
; 12: 680435, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34093582
11.
B cells and cancer: To B or not to B?
J Exp Med
; 218(1)2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33601413
12.
Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine.
Front Immunol
; 12: 701273, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322128
13.
Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s.
Cancer Immunol Res
; 9(8): 891-908, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039653
14.
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Clin Cancer Res
; 27(24): 6749-6760, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407968
15.
Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity.
PLoS One
; 16(5): e0252026, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34038475
16.
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
Front Immunol
; 11: 784, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457745
17.
The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression.
Genome Med
; 12(1): 86, 2020 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023656
18.
Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.
Clin Cancer Res
; 26(16): 4381-4389, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32269054
19.
Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067317
20.
[Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer]. / Les structures lymphoïdes tertiaires génèrent et propagent des plasmocytes produisant des anticorps antitumoraux dans le cancer du rein.
Med Sci (Paris)
; 38(6-7): 536-538, 2022.
Artigo
em Francês
| MEDLINE | ID: mdl-35766849